These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16598109)

  • 1. Drug-eluting stent strut distribution: a comparison between Cypher and Taxus by optical coherence tomography.
    Suzuki Y; Ikeno F; Yeung AC
    J Invasive Cardiol; 2006 Mar; 18(3):111-4. PubMed ID: 16598109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial.
    Okamura T; Garg S; Gutiérrez-Chico JL; Shin ES; Onuma Y; García-García HM; Rapoza RJ; Sudhir K; Regar E; Serruys PW
    EuroIntervention; 2010 Apr; 5(8):932-8. PubMed ID: 20542778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Visualization of intimal proliferation of drug-eluting stent and bare mental stent by use of optical coherence tomography].
    Chen BX; Ma FY; Luo W; Xie WL; Sun SH; Guo XM; Wang F; Zhao XZ; Chu XW
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1102-6. PubMed ID: 16796834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy and reproducibility of stent-strut thickness determined by optical coherence tomography.
    Terashima M; Rathore S; Suzuki Y; Nakayama Y; Kaneda H; Nasu K; Habara M; Katoh O; Suzuki T
    J Invasive Cardiol; 2009 Nov; 21(11):602-5. PubMed ID: 19901417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
    Silber S; Herdeg C
    Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic characteristics of late stent malapposition after drug-eluting stents implantation by optical coherence tomography follow-up.
    Hou JB; Liu HM; Ma LJ; Yang S; Meng LB; Han ZG; Zhang S; Yu B
    Chin Med J (Engl); 2010 Mar; 123(5):581-4. PubMed ID: 20367985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries.
    Wilson GJ; Nakazawa G; Schwartz RS; Huibregtse B; Poff B; Herbst TJ; Baim DS; Virmani R
    Circulation; 2009 Jul; 120(2):141-9, 1-2. PubMed ID: 19564562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model.
    Radeleff B; Thierjung H; Stampfl U; Stampfl S; Lopez-Benitez R; Sommer C; Berger I; Richter GM
    Cardiovasc Intervent Radiol; 2008; 31(5):971-80. PubMed ID: 18095019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of drug-eluting stent polymer on measurement of strut thickness by optical coherence tomography: in-vitro comparison with bare-metal stent.
    Mizuno M; Takano M; Mizuno K
    Int J Cardiol; 2010 Nov; 145(1):48-9. PubMed ID: 19398139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trials.
    Pracon R; Opolski MP; Mintz GS; Pregowski J; Kruk M; Popma JJ; Mandinov L; Wang H; Ellis SG; Grube E; Dawkins KD; Stone GW; Weissman NJ
    J Invasive Cardiol; 2014 Oct; 26(10):501-11. PubMed ID: 25274860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of neointimal coverage of overlapping sirolimus-eluting stents by optical coherence tomography.
    Tian F; Chen YD; Sun ZJ; Chen L; Yuan F; Song XT; Lü SZ
    Chin Med J (Engl); 2009 Mar; 122(6):670-4. PubMed ID: 19323932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease.
    Chen JL; Yang YJ; Gao LJ; Huang JH; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
    Chin Med J (Engl); 2008 Nov; 121(21):2144-7. PubMed ID: 19080174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography.
    Yao ZH; Matsubara T; Inada T; Suzuki Y; Suzuki T
    Chin Med J (Engl); 2008 Mar; 121(6):503-7. PubMed ID: 18364133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents.
    Otsuka Y; Chronos NA; Apkarian RP; Robinson KA
    J Invasive Cardiol; 2007 Feb; 19(2):71-6. PubMed ID: 17268041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
    Finn AV; Joner M; Nakazawa G; Kolodgie F; Newell J; John MC; Gold HK; Virmani R
    Circulation; 2007 May; 115(18):2435-41. PubMed ID: 17438147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation.
    Takano M; Inami S; Jang IK; Yamamoto M; Murakami D; Seimiya K; Ohba T; Mizuno K
    Am J Cardiol; 2007 Apr; 99(8):1033-8. PubMed ID: 17437723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of drug-eluting stent strut distribution to stent thrombosis in coronary arteries.
    Opolski MP; Pracon R; Mintz GS; Okabe T; Pregowski J; Lee SY; van der Waal EC; Kalinczuk L; Roy P; Smith KA; Torguson R; Xue Z; Satler LF; Kent KM; Pichard AD; Waksman R; Weissman NJ
    Am J Cardiol; 2009 Aug; 104(3):343-8. PubMed ID: 19616665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the late stent malposition after drug-eluting stent implantation by optical coherence tomography].
    Tian F; Chen YD; Sun ZJ; Chen L; Liu HB; Yang TS; Liu CF; Jin QH; Bai QC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jul; 37(7):585-9. PubMed ID: 19961724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of nonuniform strut distribution between two drug-eluting stent platforms.
    Hasegawa T; Ako J; Ikeno F; Waseda K; Suzuki Y; Honda Y; Fitzgerald PJ
    J Invasive Cardiol; 2007 Jun; 19(6):244-6. PubMed ID: 17541122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomographic results at six-month follow-up evaluation of the CATANIA coronary stent system with nanothin Polyzene-F surface modification (from the Assessment of The LAtest Non-Thrombogenic Angioplasty Stent [ATLANTA] trial).
    La Manna A; Capodanno D; Cera M; Di Salvo ME; Sacchetta G; Corcos T; Prati F; Tamburino C
    Am J Cardiol; 2009 Jun; 103(11):1551-5. PubMed ID: 19463514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.